PWM
RGEN icon

Parkworth Wealth Management’s Repligen RGEN Stock Holding History

Parkworth Wealth Management’s Portfolio RGEN Stock Details RGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$124 Buy
+1
New +$127 ﹤0.01% 1079

Other funds holding RGEN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Parkworth Wealth Management's RGEN Position: Q2 2025 in Review

Parkworth Wealth Management opened a new position in Repligen (RGEN) in Q2 2025: 1 share worth $124. The stake represents ﹤0.01% of the portfolio and ranks #1079 among its holdings.

443 funds tracked by Wall St. Rank hold RGEN as of Q2 2025.

  • Parkworth Wealth Management held 1 share of Repligen worth $124 as of Q2 2025.
  • Repligen was a new Parkworth Wealth Management position in Q2 2025.
  • Repligen made up ﹤0.01% of Parkworth Wealth Management's portfolio in Q2 2025, its #1079 holding.
  • 443 funds tracked by Wall St. Rank held Repligen as of Q2 2025.

Based on Parkworth Wealth Management's 13F filing for Q2 2025, filed 13 Aug 2025.